Skip to main content
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi (IST:GENIL)
Turkey flag Turkey · Delayed Price · Currency is TRY
148.90
+0.30 (0.20%)
Feb 28, 2025, 10:00 AM GMT+3

IST:GENIL Revenue

Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi had revenue of 3.78B TRY in the quarter ending September 30, 2024, with 1.22% growth. This brings the company's revenue in the last twelve months to 11.21B, down -20.82% year-over-year. In the year 2023, Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi had annual revenue of 8.15B, down -23.38%.

Revenue (ttm)
11.21B
Revenue Growth
-20.82%
P/S Ratio
4.28
Revenue / Employee
17.91M
Employees
622
Market Cap
48.00B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20238.15B-2.49B-23.38%
Dec 31, 202210.64B8.14B325.34%
Dec 31, 20212.50B351.38M16.34%
Dec 31, 20202.15B354.82M19.77%
Dec 31, 20191.80B614.71M52.08%
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MLP Saglik Hizmetleri A.S. 28.14B
Selçuk Ecza Deposu Ticaret ve Sanayi A.S. 128.62B
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. 6.05B
Deva Holding A.S. 11.00B
Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi 1.41B
Lokman Hekim Engürüsag Saglik, Turizm, Egitim Hizmetleri ve Insaat Taahhüt A.S. 2.94B
Turk Ilac Ve Serum Sanayi Anonim Sirketi 1.68B
Nasmed Özel Saglik Hizmetleri Ticaret Anonim Sirketi 732.99M
Revenue Rankings